Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: A concept elicitation study

Supportive Care in Cancer

Volumn 22, Issue 2, 2014, Pages 295-305

  Wiener, Lori ^a   Baird, Kristin ^a   Crum, Caroline ^a   Powers, Kimberly ^b   Carpenter, Paul ^c   Baker, K Scott ^c   MacMillan, Margaret L ^d   Nemecek, Eneida ^e   Lai, Jin Shei ^f   Mitchell, Sandra A ^a   Jacobsohn, David A ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c USA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Chronic graft versus host disease; Patient reported outcomes (PROs); Pediatric; Qualitative; Stem cell transplant; Symptom scale

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN;

ADOLESCENT; ARTICLE; BOTHERSOMENESS; CHILD; CHILD PARENT RELATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMPREHENSION; CORTICOSTEROID THERAPY; DISTRESS SYNDROME; GROUPS BY AGE; HUMAN; INTERVIEW; LINGUISTICS; MALE; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PUVA; QUALITATIVE RESEARCH; SCHOOL CHILD; SELF REPORT; SURVIVOR; SYMPTOM ASSESSMENT;

ADOLESCENT; ADULT; CHILD; CHRONIC DISEASE; COMMUNICATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERVIEWS AS TOPIC; MALE; PARENTS; PEDIATRICS; SELF REPORT; SURVIVORS;

EID: 84896042580     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1957-6     Document Type: Article

References (30)

1. Jacobsohn DA, Arora M, Klein JP et al (2011) Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood 118(16): 4472-4479
2. Vogelsang GB, Wagner JE (1990) Graft-versus-host disease. Hematol Oncol Clin North Am 4:625-639 (Pubitemid 20174581)
3. Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324:667-674
4. Zecca M, Prete A, Rondelli R et al (2002) Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 100:1192-1200 (Pubitemid 34864271)
5. Shulman HM, Sullivan KM, Weiden PL et al (1980) Chronic graft-versus-host syndrome inman.A long-termclinicopathologic study of 20 Seattle patients. Am J Med 69:204-217 (Pubitemid 10036817)
6. Sullivan KM, Shulman HM, Storb R et al (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57: 267-276 (Pubitemid 11174888)
7. Filipovich AH, Weisdorf D, Pavletic S et al (2005) National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl 11(12):945-956 (Pubitemid 41754712)
8. Pavletic SZ, Martin P, Lee SJ et al (2006) Measuring therapeutic response in chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transpl 12:252-266 (Pubitemid 43273710)
9. Jacobsohn DA,Kurland BF, Pidala J et al (2012) Correlation between NIH composite skin score, patient reported skin score and outcome: results from the chronic GVHD consortium. Blood 120(13):2545-2552
10. Arai S, Jagasia M, Storer B et al (2011) Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 118:4242-4249
11. Drotor D (1998) Measuring health related quality of life in children and adolescents: implications for research and practice. Lawrence Erlbaum Associates, New Jersey
12. Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P (2004) The PedsQL family impact module: preliminary reliability and validity. Health Qual Life Outcomes 2:55
13. Bhatia S, Jenney ME, Bogue MK et al (2002) The Minneapolis - Manchester quality of life instrument: reliability and validity of the adolescent form. J Clin Oncol 20:4692-4698 (Pubitemid 36025287)
14. Bhatia S, Jenney ME,Wu E et al (2004) The Minneapolis - Manchester quality of life instrument: reliability and validity of the youth form. J Pediatr 145:39-46 (Pubitemid 38962450)
15. Parsons SK, Shih MC, Mayer DK et al (2005) Preliminary psychometric evaluation of the child health ratings inventory (CHRIs) and disease-specific impairment inventory-hematopoietic stem cell transplantation (DSII-HSCT) in parents and children. Qual Life Res 14: 1613-1625 (Pubitemid 40848241)
16. Parsons SK, Shih MC, Duhamel KN et al (2006) Original research article: maternal perspectives on children's health-related quality of life during the first year after pediatric hematopoietic stem cell transplant. J Pediatr Psychol 10:1100-1115 (Pubitemid 44733927)
17. Lee S, Cook EF, Soiffer R, Antin JH (2002) Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transpl 8:444-452
18. Inamoto Y, Martin PJ, Chai X et al (2012) Clinical benefit of response in chronic graft-versus-host disease. Biol Blood Marrow Transpl 18(10):1517-1524
19. Patrick DL, Burke LB, Gwaltney CJ et al (2011) Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a New PRO instrument. Value in Health 14(8): 967-977
20. Matza LS, Patrick D, Riley AW, Alexander JJ, Rajmil L, Pleil AM, Bullinger M (2013) Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force. Value Health 16:461-479
21. DeMuro CJ, Lewis SA, DiBenedetti DB, Price MA, Fehnel SE (2012) Successful implementation of cognitive interviews in special populations. Expert Rev Pharmacoecon Outcomes Res 12(2):181-187
22. Brod M, Tesler LE, Christensen TL (2009) Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res 18:1263-1278
23. Mays N, Pope C (2000) Qualitative research in health care: assessing quality in qualitative research. Br Med J 320(7226):50
24. Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation and variability. Field Method 18(1):59-82
25. Xiao C, Polomano R, Bruner DW (2012) Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs. PMID: 23047799
26. Mitchell SA, Leidy NK, Mooney KH et al (2010) Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transpl 45(4):762-769
27. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P (2002) The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales. Multidim Fatigue Scale Cancer Module Cancer 94:2090-2106
28. Cremeens J, Eiser C, Blades M (2006) Characteristics of health-related self-report measures for children aged three to eight years: a review of the literature. Qual Life Res 15:739-754 (Pubitemid 43843981)
29. Russell KMW, Hudson M, Long A, Phipps S (2006) Assessment of health-related quality of life in children with cancer: consistency and agreement between parent and child reports. Cancer 106:2267-2274 (Pubitemid 43673250)
30. FDA: Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims (2006) Center for Drug Evaluation and Research, Food and Drug Administration, MD